Evidence map›Paper›PMID 32670573›Full record

ReviewCancer & metabolism2020

Fructose contributes to the Warburg effect for cancer growth.

Takahiko Nakagawa, Miguel A Lanaspa, Inigo San Millan, Mehdi Fini, Christopher J Rivard, Laura G Sanchez-Lozada, Ana Andres-Hernando, Dean R Tolan, Richard J Johnson

Open access · goldAbstract readReview
In one paragraph

Review in Cancer & metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 2 pooled it
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 2 syntheses or guidelines pooled it, 157 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. [Ecological analysis of the association between dietary factors and thyroid carcinoma incidence based on GBD 2021 data].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
    Article
  9. Hyperpolarized [U-ACS chemical biology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Takahiko NakagawaDepartment of Nephrology, Rakuwakai Otowa Hospital, 2 Otowa-Chinji-cho, Yamashina-ku, Kyoto, Japan.ORCID 0000-0002-0127-1529
Miguel A LanaspaDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO USA.
Inigo San MillanDepartment of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Colorado School of Medicine, Aurora, USA.
Mehdi FiniUniversity of Colorado Cancer Center, Aurora, CO USA.
Christopher J RivardDepartment of Medical Oncology, University of Colorado Denver, Aurora, CO USA.
Laura G Sanchez-LozadaDepartment of Cardio-Renal Physiopathology, Instituto Nacional de Cardiología Ignacio Chavez, 14080 Mexico City, CP Mexico.
Ana Andres-HernandoDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO USA.
Dean R TolanDepartment of Biology, Boston University, Boston, MA USA.
Richard J JohnsonDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO USA.
University of Colorado Denver · USBoston University · USInstituto Nacional de Cardiologia · BRShiga University of Medical Science · JPUniversity of Colorado Cancer Center · US

Funding

PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Edward L Melanson · 1995 to 2026
$32.6M
Targeting fructokinase, endogenous fructose production and purine degradation for the prevention and treatment of hereditary fructose intoleranceR01DK108859 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Miguel Angel Lanaspa Garcia · 2016 to 2026
$2.4M
Dietary Salt has an Unrecognized Role in Modulating Energy Intake and Metabolic SyndromeR01DK108408 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI JOHNSON, RICHARD JOSEPH · 2016 to 2019
$1.6M
NIDDK NIH HHS P30 DK048520NIDDK NIH HHS R01 DK108408NIDDK NIH HHS R01 DK108859
6 · The paper itself

Abstract

Obesity and metabolic syndrome are strongly associated with cancer, and these disorders may share a common mechanism. Recently, fructose has emerged as a driving force to develop obesity and metabolic syndrome. Thus, we assume that fructose may be the mechanism to explain why obesity and metabolic syndrome are linked with cancer. Clinical and experimental evidence showed that fructose intake was associated with cancer growth and that fructose transporters are upregulated in various malignant tumors. Interestingly, fructose metabolism can be driven under low oxygen conditions, accelerates glucose utilization, and exhibits distinct effects as compared to glucose, including production of uric acid and lactate as major byproducts. Fructose promotes the Warburg effect to preferentially downregulate mitochondrial respiration and increases aerobic glycolysis that may aid metastases that initially have low oxygen supply. In the process, uric acid may facilitate carcinogenesis by inhibiting the TCA cycle, stimulating cell proliferation by mitochondrial ROS, and blocking fatty acid oxidation. Lactate may also contribute to cancer growth by suppressing fat oxidation and inducing oncogene expression. The ability of fructose metabolism to directly stimulate the glycolytic pathway may have been protective for animals living with limited access to oxygen, but may be deleterious toward stimulating cancer growth and metastasis for humans in modern society. Blocking fructose metabolism may be a novel approach for the prevention and treatment of cancer.

Indexed as

CancerFructoseHypoxiaLactateMitochondriaPolyol pathwayUric acid

Identifiers

PMID32670573
PMCPMC7350662
OpenAlexW3041113474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.